Proton Pump Inhibitor-Treated H. pylori Adjust Cell Envelope Fatty Acid and Cholesterol Content to Survive.
CONCLUSION: Incorporation of lipophilic PPI into H. pylori cell membrane disrupted lipids and inhibited growth. However, H. pylori adjusted the defected membrane by replacing the lipid components and resisted lysis.
PMID: 31910629 [PubMed - in process]
Source: Archives of Iranian Medicine - Category: Middle East Health Authors: Kadkhodaei S, Siavoshi F, Foroumadi A, Sarrafnejad A, Kolahdoozan S Tags: Arch Iran Med Source Type: research
More News: Academies | Brain | Brucellosis | Cardiology | Cholesterol | Egg Yolk | Heart | Helicobacter Pylori | Iran Health | Lansoprazole | Middle East Health | Neurology | Pantoprazole | Prevacid | Proton Pump Inhibitors PPIs | Protonix | Study